Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2012
12/12/2012CN102816146A Flumatinib mesylate crystal form A and preparation method and use thereof
12/12/2012CN102816145A Methanesulfonic acid imatinib polymorphic substance and medical combination thereof
12/12/2012CN102816103A Vulcanized aspartic acid modified melatonin derivative and application thereof
12/12/2012CN102816081A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
12/12/2012CN102813651A Pharmaceutical composition containing esomeprazole sodium, and preparation method thereof
12/12/2012CN102206204B Benzimidazole compound and medicinal application thereof
12/12/2012CN102127055B Single-photon and two-photon homocysteine fluorescent probes and use thereof
12/12/2012CN102070611B Preparation method of amlodipine intermediate
12/12/2012CN101973946B Phenazine-1-carboxylic acids derivative and preparation method thereof
12/12/2012CN101906069B (S)-2-substituted-(3'-acetyl-2'-pyridone-1'-yl) acetic acid as well as preparation method and application thereof
12/12/2012CN101863876B Fluoroquinolone comprising 7-(3-amino-4-oximido)-1-piperidyl substitutional group and application of composition thereof
12/12/2012CN101809001B 咪唑衍生物 Imidazole derivatives
12/12/2012CN101600709B Process for the preparation of a benzimidazole derivative
12/12/2012CN101511813B Heterocyclic FXR binding compounds
12/12/2012CN101500994B 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments
12/12/2012CN101370803B Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
12/12/2012CN101253168B Substituted benzimidazoles as kinase inhibitors
12/12/2012CN101228152B N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and therapeutic use thereof
12/12/2012CN101115803B Dye, ink, ink for inkjet, inkjet recording method, ink sheet, color toner, and color filter
12/12/2012CN101061103B Anthranilamide insecticides
12/11/2012US8329912 Solid forms of 2-chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine
12/11/2012US8329907 Autotaxin inhibitors
12/11/2012US8329902 Optically pure dihydropyrimidine compounds and their uses for the preparation of a medicament for treatment and prevention of viral diseases
12/11/2012US8329900 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile
12/11/2012US8329899 Pyrazole compounds that modulate HSP90 activity
12/11/2012US8329742 Macrocyclic compounds useful as pharmaceuticals
12/11/2012US8329737 Benzimidazoles as selective kinase inhibitors
12/11/2012US8329718 N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
12/11/2012US8329713 Fused ring heterocycles as potassium channel modulators
12/11/2012US8329712 Heterocyclic antiviral compounds
12/11/2012US8329708 1,3,6-substituted indole derivatives having inhibitory activity for protein kinase
12/11/2012US8329686 Isatin analogues and uses therefor
12/11/2012US8329159 Hepatitis C virus inhibitors
12/11/2012CA2647819C Phenylcyclohexyl derivatives as dgat1 inhibitors
12/11/2012CA2576144C Sigma receptor inhibitors
12/11/2012CA2570942C Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicament
12/11/2012CA2565237C Quinoxaline inhibitors of hedgehog signalling
12/11/2012CA2515780C Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
12/06/2012WO2012166560A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
12/06/2012WO2012166559A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
12/06/2012WO2012166459A1 Tripeptides incorporating deuterium as inhibitors of hepatitis c virus
12/06/2012WO2012166390A1 Neprilysin inhibitors
12/06/2012WO2012166387A1 Neprilysin inhibitors
12/06/2012WO2012165981A1 Novel hybrid cholinesterase inhibitors
12/06/2012WO2012165832A1 Novel compounds for organic electronic material and organic electroluminescent device using the same
12/06/2012WO2012165398A1 Cycloalkyloxybiaryl compound
12/06/2012WO2012164085A1 Glycine b antagonists
12/06/2012WO2012164071A1 Imidazole derivatives
12/06/2012WO2012163925A1 Substituted terpyridines
12/06/2012WO2012163839A1 A process for the preparation of polymorphic form i of etoricoxib
12/06/2012WO2012163095A1 Pyrazole formylthiourea derivative, preparation method therefore and use thereof
12/06/2012WO2012162818A1 Substituted diarylamines and use of same as antioxidants
12/06/2012WO2012139043A3 Selective neuronal nitric oxide synthase inhibitors
12/06/2012WO2012129452A8 Propynoic acid carbamoyl methyl-amides and pharmaceutical compositions and methods based thereon
12/06/2012WO2012125447A3 Piperazinedione compounds
12/06/2012WO2012012891A8 Compounds, compositions and methods for treatment of arthritis
12/06/2012US20120309976 Preparation process of the sodium salt of esomeprazole
12/06/2012US20120309974 Bianthracene compounds substituted by aromatic ring and their uses for luminescence materials
12/06/2012US20120309972 Tetrazolyloxime derivative or salt thereof and fungicide
12/06/2012US20120309969 Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((s)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone
12/06/2012US20120309964 Cyclic amine compound and acaricide
12/06/2012US20120309938 Hemiasterlin derivatives and uses thereof in the treatment of cancer
12/06/2012US20120309794 Compounds inhibitors of enzyme lactate dehydrogenase (ldh) and pharmaceutical compositions containing these compounds
12/06/2012US20120309792 Tetrazole derivatives as nicotinic acetylcholine receptor modulators
12/06/2012US20120309791 Novel compound for the treatment of diseases associated with amyloid or amyloid-like proteins
12/06/2012US20120309789 Compounds which have activity at M1 receptor and their uses in medicine
12/06/2012US20120309786 3-amino-pyridine derivatives for the treatment of metabolic disorders
12/06/2012US20120309777 Substituted 2-imidazolidones and analogs
12/06/2012US20120309771 Novel antifungal triazole derivatives
12/06/2012US20120309769 N-benzylindole modulators of pparg
12/06/2012US20120309767 Process for the preparation of alpha form of imatinib mesylate
12/06/2012US20120309760 Piperazine compound having a pgds inhibitory effect
12/06/2012US20120309759 Screening Method and Compounds for Modulating Telomerase Activity
12/06/2012US20120309758 Modulators of atp-binding cassette transporters
12/06/2012US20120309757 N-biphenylmethylindole modulators of pparg
12/06/2012US20120309751 Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
12/06/2012US20120309742 Use of metabotropic glutamate receptors
12/06/2012US20120309741 Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors
12/06/2012US20120309738 Novel compounds
12/06/2012US20120309736 Novel cyclic benzimidazole derivatives useful anti-diabetic agents
12/06/2012US20120308589 Sinomenine derivatives, synthetic methods and uses thereof
12/06/2012US20120308587 Neprilysin inhibitors
12/06/2012CA2837586A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
12/06/2012CA2837517A1 Imidazole derivatives
12/06/2012CA2837167A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
12/06/2012CA2835220A1 Neprilysin inhibitors
12/06/2012CA2835216A1 Neprilysin inhibitors
12/05/2012EP2530082A1 Process for preparing 2, 3-disubstituted indoles
12/05/2012EP2530081A2 Nilotinib HCI crystalline forms
12/05/2012EP2530077A1 Novel method for preparing imatinib base
12/05/2012EP2530075A2 Modulators of ATP-binding cassette transporters
12/05/2012EP2529738A1 Substituted terpyridines
12/05/2012EP2528912A1 Process for the preparation of crystalline forms of dexlansoprazole
12/05/2012EP2528911A2 Compositions and methods for enhancing proteasome activity
12/05/2012EP2528910A1 5-alkynyl pyrimidines and their use as kinase inhibitors
12/05/2012EP2528909A1 Sulfonamido derivatives of 3,4-diarylpyrazoles as protein kinase inhibitors
12/05/2012EP2528903A1 5-alkynyl-pyrimidines
12/05/2012EP2528902A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
12/05/2012EP2528898A2 NOVEL COMPOSITIONS FOR REDUCING Aß 42 PRODUCTION AND THEIR USE IN TREATING ALZHEIMER'S DISEASE (AD)
12/05/2012EP2528897A1 Di - substituted pyridine derivatives as anticancers
1 ... 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 ... 1080